Menu

Pharma News

China Sub Page Image

Actavis sells interest in China

Home/Pharma News | Posted 14/02/2014

US generic drugmaker Actavis has sold its interest in its Chinese subsidiary based in Foshan, Guangdong, to Zhejiang Chiral Medicine Chemicals. Actavis, the second biggest generic drugmaker by market capitalization, intends to continue further commercial operations in China in collaboration with its preferred business partners.

Generics Blue Cap V13C15

Aurobindo to acquire seven generics businesses from Actavis

Home/Pharma News | Posted 31/01/2014

US generics maker Actavis and Indian generics maker Aurobindo Pharma (Aurobindo) announced on 17 January 2014 the signing of an offer for Aurobindo to acquire generics commercial operations in seven markets in Western Europe from Actavis.

Generic V13C05

Pfizer’s generics business up for grabs

Home/Pharma News | Posted 24/01/2014

In 2013, Pfizer, the world’s largest drugmaker, split its business into two brand-name drug units and a generics business. Now it seems the generics unit, or its ‘established products’ unit, is being circled for a potential takeover bid.

Drug Shortages FDA V13K15

Pricing dispute causing drug shortages in Pakistan

Home/Pharma News | Posted 17/01/2014

Pharmaceutical manufacturers in Pakistan are warning the Pakistan Government that shortages in life-saving drugs are a result of the ongoing dispute over drug prices.

Ireland’s IPHA hits back at high drug prices claim

Home/Pharma News | Posted 13/12/2013

The Irish Pharmaceutical Healthcare Association (IPHA) has hit back at statements from the European Commission’s (EC’s) troika that drug prices in the country are unjustifiably high.

Oxycodone V13D19

Health Canada approves generic oxycodone despite fears of abuse

Home/Pharma News | Posted 29/11/2013

Canada’s drug regulator Health Canada has approved a generic non-crush resistant form of oxycodone, despite the fact that US officials have been urging their Canadian counterpart to ban such formulation of the powerful painkiller.

Health on a Budget V13D12

Ireland high drug prices cannot be justified

Home/Pharma News | Posted 22/11/2013

The European Commission’s troika mission to Ireland has told Government TDs (Members of Parliament) that the cost of pharmaceutical drugs in the country cannot be justified. Drug prices in the country have been found to be at least three times more expensive than in the UK.

Drug Shortages FDA V13K15

EMA launches public catalogue of drug shortages

Home/Pharma News | Posted 15/11/2013

The European Medicines Agency (EMA) announced on 4 November 2013 the launch of its public catalogue on supply shortages of drugs.

picture28

FDA announces two actions to combat drug shortages

Home/Pharma News | Posted 08/11/2013

The US Food and Drug Administration (FDA) announced on 31 October 2013 that it is taking two important actions to further enhance the agency’s ongoing efforts to prevent and resolve drug shortages.

Health on a Budget V13D12

Australia should not copy New Zealand’s drug pricing system

Home/Pharma News | Posted 25/10/2013

Australia should resist ongoing pressure to adopt a New Zealand-style model of medicines funding, according to Medicines Australia, a group that represents originator manufacturers.

Internet Pharmacy V13J18

US state introduces law to allow meds to be bought over Internet

Home/Pharma News | Posted 18/10/2013

On 9 October 2013, the US state of Maine introduced a law allowing its residents to purchase foreign prescription drugs over the Internet.

Approved V13G05

India approves Mylan’s purchase of Agila

Home/Pharma News | Posted 11/10/2013

Generics giant Mylan announced on 3 September 2013 that its proposed acquisition of generics injectables maker Agila Specialties (Agila) from Strides Arcolab for Rs 5,168-crore (US$1.6 billion) had been cleared by the Indian Government.

Drug shortages V13C22

Johnson & Johnson warns of shortages of cancer drug Doxil

Home/Pharma News | Posted 04/10/2013

Janssen Pharmaceutical Companies (Janssen), a division of healthcare giant Johnson & Johnson, has warned of impending shortages of its ovarian cancer drug Doxil (doxorubicin).

SurePal Pen V13I27

Sandoz launches new device for its biosimilar somatropin

Home/Pharma News | Posted 27/09/2013

Sandoz, the generic drug division of Swiss drug giant Novartis, announced on 23 September 2013 the launch of a new delivery device for its biosimilar somatropin product (Omnitrope) in the UK.

Business Aquisition V13F07

Akorn to buy Hi-Tech Pharmacal for US$640 million

Home/Pharma News | Posted 13/09/2013

Generic eye-drugmaker Akorn has entered into a deal to buy Hi-Tech Pharmacal (Hi-Tech) for US$640 million in cash to expand into oral liquids and ointments, including cold and cough treatments.

Generic Brand Name V13C01

Endo to buy specialty generic drugmaker Boca Pharmacal

Home/Pharma News | Posted 06/09/2013

Specialty pharmaceutical maker Endo Health Solutions (Endo) announced on 28 August 2013 that its generics subsidiary, Qualitest, has agreed to buy specialty generic drugmaker Boca Pharmacal (Boca) for US$225 million in cash.

picture 87

Actavis and Bioton form joint venture for insulin

Home/Pharma News | Posted 03/02/2012

Icelandic generics manufacturer Actavis announced on 30 January 2012 that it had formed a joint venture company with Polish biotechnology company Bioton for the development and registration of insulin products, including analogue insulins.

Health on a Budget V13D12

Philippines urged to import drugs from Bangladesh

Home/Pharma News | Posted 10/05/2013

The Prime Minister of Bangladesh, Ms Sheikh Hasina, on 5 May 2013 urged the Philippines to import pharmaceutical products from Bangladesh, particularly for the countries governmental hospitals and clinics, due to the significant cost-savings to be made.

picture 116

Generics manufacturers increase investment in injectables

Home/Pharma News | Posted 30/08/2013

Generic drugmaker Zydus Cadila, the fifth largest pharmaceutical company in India, is set to invest about US$15.8 million in building an FDA-approved injectables-manufacturing plant. The news in August 2013 came just as Aurobindo Pharma announced plans to spin-off its injectables business to strengthen that side of its operations further.

picture 116

Fresenius Kabi sets up generics joint venture in Indonesia

Home/Pharma News | Posted 23/08/2013

Fresenius Kabi, the generics unit of healthcare giant Fresenius, announced on 19 August 2013 that it had set up a joint venture with Indonesia-based PT Soho Global Health, acquiring a 51% share in its subsidiary PT Ethica Industri Farmasi.